04 Jun 2019   |   Network Updates   |   Update from Elsevier / RELX
These updates are republished press releases and communications from members of the Science|Business Network

Elsevier-Poland agreement for national license boosts access to high quality research

Elsevier, the information analytics business specializing in science and health, and the Polish consortium for higher education, today agreed on a national license agreement for access to critical academic research, while advancing Poland’s open access objectives. The new three-year national license is based on a thorough analysis of the Polish requirements for access to research, the country’s publishing choices and its focus on research quality. It provides over 500 universities and research institutions across the country with access to ScienceDirect, Elsevier’s leading platform of peer-reviewed scholarly literature, as well as SciVal, the research performance tool, and Scopus, the largest abstract and citation database of peer-reviewed literature.

The Polish research community will have access to the highest-quality research published in Elsevier journals and titles by its society partners. As part of the agreement, Elsevier will also help the Polish consortium, led by the Interdisciplinary Centre for Mathematical and Computational Modelling (ICM), University of Warsaw (UW), to support open access publishing.

“We’re delighted to reach this agreement with Elsevier as it enables access to the high-quality research that is vital for our students and researchers. It will advance our ambitious research agenda,” said Dr. Marek Michalewicz, Director at ICM, UW. “In addition, through the inclusion of an open access component, we have made important steps towards enabling Polish research to gain free accessibility and visibility.”

Access to Scopus and SciVal will support Polish research in benchmarking its performance against more than 10,700 research institutions and their associated researchers from across the world, supporting the quality of Polish academic programs.

“We look forward to continuing to support the Polish research community as it carries out its vitally important work,” said Gino Ussi, Elsevier’s Executive Vice President. “Elsevier’s approach has been to engage with ICM to understand its specific objectives and to work closely with its team to create an innovative agreement.

“This new national license supports the Polish research community by providing access to the highest-quality research while enabling it to manage the Polish research landscape strategically. The license will also help Poland achieve its ambitious Open Science objectives.”


About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirectScopusSciValClinicalKeyand Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

This release was first published 3 June 2019 by Elsevier.

Never miss an update from Science|Business:   Newsletter sign-up